Table 2 Lesion and procedure data
Zotarolimus-eluting stent n = 810 | Sirolimus-eluting stent n = 787 | p | |
|---|---|---|---|
Number of treated lesions per patient | 0.04 | ||
2 | 230 (65.7%) | 254 (73.6%) | |
3 | 91 (26.0%) | 63 (18.3%) | |
> 3 | 29 (8.3%) | 28 (8.1%) | |
Number of treated vessels per patient | 0.21 | ||
1 | 115 (32.9%) | 107 (31.0%) | |
2 | 188 (53.7%) | 207 (60.0%) | |
3 | 47 (13.4%) | 31(9.0%) | |
Target lesion coronary artery | 0.45 | ||
Left main | 17 (2.1%) | 13 (1.7%) | |
Left anterior descending | 308 (38.0%) | 267 (33.9%) | |
Left circumflex | 222 (27.4%) | 229 (29.1%) | |
Right | 261 (32.2%) | 276 (35.1%) | |
Bypass graft | 2 (0.2%) | 2 (0.3%) | |
Lesion type | 0.09 | ||
A | 156 (19.3%) | 136 (17.5) | |
B | 336 (41.6%) | 365 (47.1) | |
C | 316 (39.1%) | 274 (35.4) | |
Length of stented segment per lesion (mm) | 19.5 (11.4) | 19.7 (12.2) | 0.77 |
Length of stented segment per patient (mm) | 45.2 (20.8) | 44.9 (20.9) | 0.87 |
Maximal stent diameter (mm) | 3.2 (0.5) | 3.2 (0.5) | 0.84 |
Use of glycoprotein IIb/IIIa inhibitors | 75 (21.4%) | 87 (25.2%) | 0.24 |
Assigned study stent could not be implanted | 1 (0.1%) | 11 (1.4%) | 0.003 |